Safety, Feasibility and Cost-effectiveness of Genotype-directed Individualized Dosing of Fluoropyrimidines
Clinical trial NCT02324452 · COMPLETED
Trial details
- NCT number
- NCT02324452
- Sponsor
- The Netherlands Cancer Institute
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-01
- Primary completion
- 2018-01-01
- Enrollment
- 1103
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.